UA104138C2 - Novel adjuvant compositions - Google Patents

Novel adjuvant compositions

Info

Publication number
UA104138C2
UA104138C2 UAA201013068A UAA201013068A UA104138C2 UA 104138 C2 UA104138 C2 UA 104138C2 UA A201013068 A UAA201013068 A UA A201013068A UA A201013068 A UAA201013068 A UA A201013068A UA 104138 C2 UA104138 C2 UA 104138C2
Authority
UA
Ukraine
Prior art keywords
adjuvant compositions
novel adjuvant
formulations
adjuvant
compositions
Prior art date
Application number
UAA201013068A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Седо Мартин БАГИ
Тедд Алан Чилдерс
Пол Джозеф Доминовски
Ричард Ли КРЕБС
Рамасами Маннар МАННАН
Мари Кетрин Ольсен
Джеймс Ричард ТОМПСОН
Рисини Даммика Вератна
Роберт Джон Джр. Янсей
Шу Зан
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Priority claimed from PCT/IB2009/052724 external-priority patent/WO2009156960A2/en
Publication of UA104138C2 publication Critical patent/UA104138C2/en

Links

Abstract

This invention relates to adjuvant formulations comprising various combinations of thterpenoids, steroid, immunomodulators, polymers, and Th2 stimulators; methods for making the adjuvant compositions; and the use of the adjuvant formulations in immunogenic and vaccine compositions with different antigens. This invention further relates to the use of the formulations in the treatment of animals.
UAA201013068A 2008-06-27 2009-06-24 Novel adjuvant compositions UA104138C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7623208P 2008-06-27 2008-06-27
PCT/IB2009/052724 WO2009156960A2 (en) 2008-06-27 2009-06-24 Novel adjuvant compositions

Publications (1)

Publication Number Publication Date
UA104138C2 true UA104138C2 (en) 2014-01-10

Family

ID=52297695

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201013068A UA104138C2 (en) 2008-06-27 2009-06-24 Novel adjuvant compositions

Country Status (2)

Country Link
AR (2) AR111910A2 (en)
UA (1) UA104138C2 (en)

Also Published As

Publication number Publication date
AR111911A2 (en) 2019-08-28
AR111910A2 (en) 2019-08-28

Similar Documents

Publication Publication Date Title
PH12014501835A1 (en) Novel adjuvant compositions
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
IN2012DN01898A (en)
MX352324B (en) Multivalent synthetic nanocarrier vaccines.
CA2759013C (en) Combination immunotherapy compositions against cancer and methods
MX2011007930A (en) Crystalline insulin-conjugates.
IN2012DN02736A (en)
MX364200B (en) Novel compositions and methods for the treatment of immune related diseases.
IN2015DN02826A (en)
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
HN2011003011A (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
EP2574170A4 (en) Immunostimulatory and vaccine compositions
MY152437A (en) Oral care compositions
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
WO2012103444A3 (en) Immunogenic compositions and reagents for preparing
WO2014100857A8 (en) Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
MX2014010958A (en) Activated immunostimulatory cell composition and uses thereof.
MX350718B (en) Equine rhinitis vaccine.
UA104138C2 (en) Novel adjuvant compositions
BRPI1008721A2 (en) methods for therapeutic or prophylactic treatment of hiv, prophylactic method, therapeutic composition or preparation, combination of therapeutic vaccine, therapeutic method implantation kit
WO2012149525A3 (en) Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
TR201907091T4 (en) New adjuvant compositions.
UA106224C2 (en) Crystalline insulin-conjugates
TN2010000338A1 (en) Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant